Harnessing Bifunctional Ferritin with Kartogenin Loading for Mesenchymal Stem Cell Capture and Enhancing Chondrogenesis in Cartilage Regeneration

2022 ◽  
pp. 2101715
Author(s):  
En Ren ◽  
Haimin Chen ◽  
Zainen Qin ◽  
Siwen Guan ◽  
Lai Jiang ◽  
...  
JCI Insight ◽  
2017 ◽  
Vol 2 (20) ◽  
Author(s):  
Daniela Zwolanek ◽  
María Satué ◽  
Verena Proell ◽  
José R. Godoy ◽  
Kathrin I. Odörfer ◽  
...  

2009 ◽  
Vol 18 (9) ◽  
pp. 1013-1028 ◽  
Author(s):  
Tom K. Kuo ◽  
Jennifer H. Ho ◽  
Oscar K. Lee

Mesenchymal stem cells are stem/progenitor cells originated from the mesoderm and can different into multiple cell types of the musculoskeletal system. The vast differentiation potential and the relative ease for culture expansion have established mesenchymal stem cells as the building blocks in cell therapy and tissue engineering applications for a variety of musculoskeletal diseases, including repair of fractures and bone defects, cartilage regeneration, treatment of osteonecrosis of the femoral head, and correction of genetic diseases such as osteogenesis imperfect. However, research in the past decade has revealed differentiation potentials of mesenchymal stem cells beyond lineages of the mesoderm, suggesting broader applications than originally perceived. In this article, we review the recent developments in mesenchymal stem cell research with respect to their emerging properties and applications in nonmusculoskeletal diseases.


2017 ◽  
Vol 23 (6) ◽  
pp. 529-539 ◽  
Author(s):  
Marta A. Szychlinska ◽  
Martin J. Stoddart ◽  
Ugo D'Amora ◽  
Luigi Ambrosio ◽  
Mauro Alini ◽  
...  

Author(s):  
Sharon Si Heng Tan ◽  
Calvin Kai En Tjio ◽  
Joshua Rui Yen Wong ◽  
Keng Lin Wong ◽  
Jacob Ren Jie Chew ◽  
...  

2020 ◽  
Author(s):  
Julien Freitag ◽  
James Wickham ◽  
Kiran Shah ◽  
Douglas Li ◽  
Cameron Norsworthy ◽  
...  

Aim: To evaluate the safety and efficacy of adipose-derived mesenchymal stem cell (ADMSC) therapy in combination with arthroscopic abrasion arthroplasty (AAA) in advanced knee osteoarthritis (OA). Materials & methods: 27 patients with Grade IV OA of the knee underwent AAA and ADMSC therapy (50 × 106 ADMSCs at baseline and 6 months). Clinical outcome was assessed over 36 months. Structural change was determined using MRI. Results: Treatment was well tolerated with no serious adverse events. Clinically significant improvements in pain and function were observed. Reproducible hyaline-like cartilage regeneration was seen in all participants. Conclusion: ADMSC therapy combined with AAA in Grade IV OA results in reproducible pain, functional and structural improvements. This represents a joint preservation technique for patients with advanced OA of the knee. Trial registration number: ACTRN12617000638336


Sign in / Sign up

Export Citation Format

Share Document